Menu

Eye on the Tiger

Following a century of decline, the global population of wild tigers grows.

Apr 13, 2016
Catherine Offord

WIKIMEDIA, DAVE PAPEThe minimum number of tigers living in the wild is estimated to be close to 3,900 this year, up from 3,200 in 2010, marking the first population increase in more than a century. The new estimate was announced this weekend (April 10) by the World Wildlife Fund (WWF) and the Global Tiger Forum ahead of the 3rd Asia Ministerial Conference on Tiger Conservation in New Delhi this week.

“This is a pivotal step in the recovery of one of the world’s most endangered and iconic species,” Ginette Hemley, senior vice president of wildlife conservation at WWF, said in a statement. “Together with governments, local communities, philanthropists, and other NGOs, we’ve begun to reverse the trend in the century-long decline of tigers.”

The increase over the last six years reflects rising populations of tigers in several of 13 countries that pledged to double wild tiger numbers within 12 years following the 2010 Global Tiger Summit (the so-called Tx2 goal), Hemley told Scientific American. “The countries where we’re seeing high-level commitment—Russia, India, Nepal and Bhutan—are the ones where we’ve seen the biggest progress.”

The population estimates are subject to considerable error for some regions, such as in several countries—including Indonesia and Malaysia—that have not taken part in systematic surveys. And even in countries where population counts are more readily available, the surveys provide no information about the subspecies represented in each region, or the state of habitat fragmentation—a factor that could influence future population growth or decline.

Nonetheless, governments attending the meeting in New Delhi this week will be able to use the new estimates to inform conservation strategies aiming to boost this trend in tiger population numbers, Rajesh Gopal, secretary general of the Global Tiger Forum, told WWF. “This is a critical meeting taking place at the halfway point in the Tx2 goal,” he said. “Tiger governments will decide the next steps towards achieving this goal and ensuring wild tigers have a place in Asia’s future.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.